Cipher Pharmaceuticals Stock Volatility
| CPHRF Stock | USD 10.97 -0.18 -1.61% |
Cipher Pharmaceuticals exhibits a low volatility profile over the current measurement period. From an efficiency perspective, Cipher Pharmaceuticals records a Sharpe Ratio (Efficiency) of 0.0546, indicating measured return efficiency over the last 3 months. Our analysis points to 30 technical indicators driving current risk behavior.
Sharpe Ratio = 0.0546
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | CPHRF | High Risk | Huge Risk |
| Negative Returns |
Cipher Pharmaceuticals's financial profile includes a Market Risk Adjusted Performance of -0.3%, a Risk of 1.56, and a Risk Adjusted Performance of 0.05%. At about 4% of its historical trend bandwidth, Cipher Pharmaceuticals is operating within prior boundaries. Its impact depends on correlation and volatility interaction.
Key indicators related to Cipher Pharmaceuticals' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Managing volatility risk for Cipher Pharmaceuticals positions requires understanding whether Cipher Pharmaceuticals' elevated volatility is driven by fundamental changes or temporary market sentiment. Fundamental-driven volatility for Cipher Pharmaceuticals tends to persist longer than sentiment-driven spikes.
Cipher |
Cipher Pharmaceuticals Volatility Strategy
Cipher Pharmaceuticals return swings may impact long-term portfolio variance. Current statistical measures show total volatility near 1.56% with a beta coefficient of -0.24, indicating sensitivity relative to the broader market benchmark. Risk-adjusted efficiency, represented by a Sharpe ratio of 0.0546, evaluates return per unit of total risk. An alpha value of 0.0756 reflects performance relative to systematic market exposure. Expected return estimates near 0.0853% are derived from historical distribution modeling and help frame forward-looking return assumptions within a portfolio context. Growth repricing can increase short-term volatility.
Main indicators related to Cipher Pharmaceuticals' market risk premium analysis include:
Beta -0.24 | Alpha 0.0756 | Risk 1.56 | Sharpe Ratio 0.0546 | Expected Return 0.0853 |
Moving against Cipher OTC Stock
| 0.39 | AXP | American Express | PairCorr |
| 0.37 | HPQ | HP Inc Aggressive Push | PairCorr |
| 0.31 | BAC | Bank of America | PairCorr |
Cipher Pharmaceuticals Sensitivity To Market
Cipher Pharmaceuticals'Cipher Pharmaceuticals demonstrates a beta of -0.24, indicating market-linked volatility exposure. Regression slope interpretation supports this systematic risk estimate. Total volatility measures approximately 1.56%.Cipher Pharmaceuticals volatility can be described using downside deviation (1.35%), which captures negative-return intensity over the selected horizon. For Cipher Pharmaceuticals, dispersion metrics describe what happened historically across the selected window.
| α | 0.08 | β | -0.2437 | Check current 90 days Cipher Pharmaceuticals correlation with market (Dow Jones Industrial)
Cipher Pharmaceuticals Downside Risk
Cipher standard deviation quantifies the magnitude of daily price swings relative to the average over the selected period. More volatile instruments exhibit higher standard deviations. This measure counts all price dispersion as risk, including returns above the mean.
Standard Deviation | 1.56 |
Standard deviation of Cipher Pharmaceuticals captures both favorable and adverse price swings. Downside deviation and semi-deviation focus exclusively on the adverse side of Cipher Pharmaceuticals' return distribution. Cipher Pharmaceuticals's financial profile includes a Downside Deviation of 1.35, a Downside Variance of 1.83, and a Maximum Drawdown of 7.95.
Cipher Pharmaceuticals OTC Stock Volatility Analysis
Volatility is a core concept when evaluating Cipher Pharmaceuticals as part of a diversified portfolio. The otc stock's historical price swings give investors a sense of how much risk Cipher Pharmaceuticals' adds. Combining Cipher Pharmaceuticals with lower-volatility assets can reduce overall portfolio risk.
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cipher Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Cipher Pharmaceuticals Projected Return Density Against Market
Assuming the 90 days horizon Cipher Pharmaceuticals has a beta of -0.2437 suggesting as returns on the benchmark increase, returns on holding Cipher Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Cipher Pharmaceuticals is likely to outperform the market.Market risk ties Cipher Pharmaceuticals to macro cycles, whereas company or sector-specific developments represent independent drivers. Volatility metrics help measure this balance. Cipher Pharmaceuticals's financial profile includes a Downside Deviation of 1.35, a Mean Deviation of 1.22, and a Semi Deviation of 1.25.
Predicted Return Density |
| Returns |
What Drives a Cipher Pharmaceuticals Price Volatility?
Several factors can influence a otc's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Cipher Pharmaceuticals OTC Stock Risk Measures
Assuming the 90 days horizon the coefficient of variation of Cipher Pharmaceuticals is 1830.17. The daily returns are distributed with a variance of 2.43 and standard deviation of 1.56. The mean deviation of Cipher Pharmaceuticals is currently at 1.22. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.78
α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | -0.2437 | |
σ | Overall volatility | 1.56 | |
Ir | Information ratio | 0.05 |
Cipher Pharmaceuticals OTC Stock Return Volatility
Cipher Pharmaceuticals historical daily return volatility represents how much of Cipher Pharmaceuticals otc's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 1.5604% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.7925% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cipher OTC Stock performing well and Cipher Pharmaceuticals OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cipher Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BHCCF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ABTI | 31.75 | 15.76 | 0.00 | 1.63 | 0.00 | 0.00 | 1,022 | |||
| BHHKF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MAYNF | 1.55 | -0.51 | 0.00 | -2.46 | 0.00 | 1.64 | 21.90 | |||
| TSNLF | 0.49 | 0.25 | 0.00 | 1.22 | 0.00 | 0.00 | 7.59 | |||
| TRGNF | 1.62 | 0.70 | 0.00 | 0.59 | 0.00 | 0.00 | 61.69 | |||
| AONC | 5.58 | 1.11 | 0.05 | 0.24 | 8.07 | 4.55 | 143.49 | |||
| HNSBF | 0.01 | -0.02 | 0.00 | 1.04 | 0.00 | 0.00 | 0.34 | |||
| PSIQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NIKA | 4.30 | 2.20 | 0.00 | -21.39 | 0.00 | 7.69 | 94.87 |
Cipher Pharmaceuticals Risk and Return Dispersion
Volatility for Cipher Pharmaceuticals measures return dispersion and uncertainty over time. Uncertainty impacts position sizing assumptions in portfolio models. Cipher Pharmaceuticals is assessed in terms of its structural contribution to portfolio diversification and long-term stability.
Methodology
Unless otherwise specified, financial data for Cipher Pharmaceuticals is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Cipher (USA Stocks:CPHRF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Volatility figures, standard deviation, and downside-risk estimates on this page are derived from historical return distributions.
Assumptions
Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Cipher Pharmaceuticals may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Cipher Pharmaceuticals Investment Opportunity
Measured over the selected horizon, Cipher Pharmaceuticals carries roughly 1.97 times the return volatility of Dow Jones Industrial. That added volatility may be acceptable only if the position is expected to deliver stronger return efficiency or diversification value.You can use Cipher Pharmaceuticals to protect your portfolios against small market fluctuations. This price-change note interprets the latest move in the context of short-horizon trading behavior. It is most useful when combined with broader risk controls and position-sizing discipline. a bearish sentiment with high volatility. Check odds of Cipher Pharmaceuticals to be traded at $10.64 in 90 days.Significant diversification
Across the chosen horizon, CPHRF and DJI show a correlation of 0.07 and fall into the Significant diversification bucket. In portfolio terms, the overlap visualization shows how much shared movement remains after both positions are combined.
Cipher Pharmaceuticals Additional Risk Indicators
Risk analysis around Cipher Pharmaceuticals becomes more useful when investors review secondary indicators that can confirm, refine, or challenge the basic volatility picture. Used correctly, these measures can support both standalone risk assessment and portfolio-level hedging decisions.
| Risk Adjusted Performance | 0.0475 | |||
| Market Risk Adjusted Performance | -0.30 | |||
| Mean Deviation | 1.22 | |||
| Semi Deviation | 1.25 | |||
| Downside Deviation | 1.35 | |||
| Coefficient Of Variation | 1830.17 | |||
| Standard Deviation | 1.56 |
Cipher Pharmaceuticals Suggested Diversification Pairs
Pair trading with Cipher Pharmaceuticals can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Cipher Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Cipher Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Cipher Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Cipher Pharmaceuticals.
Popular Tools for Cipher OTC Stock analysis
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |